Work

102 Characterization of ORKA-002, a Novel Extended Half-life Monoclonal Antibody Targeting IL-17A/F for the Treatment of Psoriasis and Other Indications

Year: 2025

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2025.09.120

Authors: Byron Kwan, Joseph Merola, Andrew Blauvelt, Daniel Rios, Joana Ministro, Jacob Milligan, Ghassan Fayad, Christopher Finch, Eugenia Levi, Joseph Senn, Jason Oh, Hussam Shaheen

Institution: The University of Texas Southwestern Medical Center

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416075944

FWCI:

Cites:

Cited by:

Related to: 10